NSPXD:Rebus Holdings Inc - Stock Price Quote and Dividend Data
NSPXD STOCK PRICE LATEST CLOSE
$0.10
EXCHANGE
OTCBB
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Rebus Holdings Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Rebus Holdings Inc Stock Price Information
52-Week Low/High Stock Price$0.08 - $4.28
Percent Held by Institutions0.00%
Revenue$0
Net Income$9,283,000
Cash Flow$-128,000
EPS2.25%
Market Cap$689,438
PE Ratio to Industry45%
Debt-Equity Ratio1,000,000.00%
Debt-Equity to Industry1.05%
Total Return Last 12 Months-90.16%
Total Return Last 3 Years-99.96%
Total Return Last 5 Years-100.00%
Latest Trade DateNov. 08, 2021
Rebus Holdings Inc Annual Stock Dividends
No Data available for Payment History.
Rebus Holdings Inc Dividend Payment History
No dividends retrieved for NSPXD |
Rebus Holdings Inc Other Dividend Details
Inspyr Therapeutics is a clinical-stage, pre-revenue, pharmaceutical company primarily focused on the development of therapeutics for the treatment of diseases. Through its wholly owned subsidiary, Lewis & Clark Pharmaceuticals, Inc., Co. is focusing on a pipeline of small molecule adenosine receptor modulators. The adenosine receptor modulators include A2B antagonists, dual A2A/A2B antagonists, and A2A agonists that have development applicability including indications within immuno-oncology and inflammation. Adenosine is implicated in immunosuppression in the tumor microenvironment. Adenosine also has anti-inflammatory properties in the acute and chronic setting.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Nov. 05, 2021NSPXD STOCK PRICE DECREASE: Rebus Holdings Inc on 11-05-2021 decreased stock price > 10% from $0.11 to $0.10
Oct. 19, 2021NSPXD STOCK PRICE INCREASE: Rebus Holdings Inc on 10-19-2021 increased stock price > 10% from $0.11 to $0.13
Oct. 14, 2021NSPXD STOCK PRICE DECREASE: Rebus Holdings Inc on 10-14-2021 decreased stock price > 10% from $0.15 to $0.13
Oct. 13, 2021NSPXD STOCK PRICE INCREASE: Rebus Holdings Inc on 10-13-2021 increased stock price > 10% from $0.04 to $0.15
Jul. 25, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-25-2020 decreased close price > 10% from $0.05 to $0.04
Jul. 24, 2020CLOSE PRICE INCREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-24-2020 increased close price > 10% from $0.04 to $0.05
Jul. 23, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-23-2020 decreased close price > 10% from $0.05 to $0.04
Jul. 22, 2020CLOSE PRICE INCREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-22-2020 increased close price > 10% from $0.04 to $0.05
Jul. 21, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-21-2020 decreased close price > 10% from $0.05 to $0.04
Jul. 15, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-15-2020 decreased close price > 10% from $0.05 to $0.04
Dec. 14, 2024APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 12-14-2024 decreased stock price > 10% from $0.22 to $0.16
Dec. 14, 2024QTTB STOCK PRICE DECREASE: Q32 Bio Inc on 12-14-2024 decreased stock price > 10% from $4.25 to $3.70
Dec. 14, 2024APVO STOCK PRICE DECREASE: Com Par $0.001/Aptevo Therapeutics Inc on 12-14-2024 decreased stock price > 10% from $5.63 to $4.09
Dec. 14, 2024CHRO STOCK PRICE DECREASE: Chromocell Therapeutics Corp on 12-14-2024 decreased stock price > 10% from $0.69 to $0.59
Dec. 14, 2024DTIL STOCK PRICE DECREASE: Precision Biosciences Inc on 12-14-2024 decreased stock price > 10% from $6.12 to $5.44
Dec. 14, 2024MGX STOCK PRICE DECREASE: Metagenomi Inc on 12-14-2024 decreased stock price > 10% from $3.86 to $3.24
Dec. 14, 2024INO STOCK PRICE DECREASE: Com Par $0.001/Inovio Pharmaceuticals Inc. on 12-14-2024 decreased stock price > 10% from $3.76 to $2.32
Dec. 14, 2024ONCO STOCK PRICE DECREASE: Onconetix Inc on 12-14-2024 decreased stock price > 10% from $0.47 to $0.40
Dec. 14, 2024TTOO STOCK PRICE DECREASE: Com Par $0.001/T2 Biosystems Inc on 12-14-2024 decreased stock price > 10% from $0.45 to $0.37
Dec. 14, 2024SHOTW STOCK PRICE DECREASE: Wt Exp/Safety Shot Inc on 12-14-2024 decreased stock price > 10% from $0.25 to $0.22